Fundraising Fox
Sanara MedTech
NASDAQ: SMTIFort Worth, US · Texas corporation
Find your way into Sanara MedTech
Sign up to see every warm intro you have to Sanara MedTech
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Sanara MedTech team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Sanara MedTech is a medical technology company focused on wound care and related healthcare products. The page lists its board of directors and executive leadership.
Founders & leadership
ZB
Zachary B. FlemingChief Executive Officer
MD
Michael D. McNeilChief Financial Officer
RN
Ron NixonChairman (Executive Chairman) & former CEO
JW
James W. StuckertNamed on SEC filing
RM
Roszell Mack IIINamed on SEC filing
AB
Ann Beal SalamoneNamed on SEC filing
RA
Robert A. DeSutterNamed on SEC filing
ED
Eric D. MajorNamed on SEC filing
SN
Sara N. OrtweinNamed on SEC filing
ED
Eric D. TanzbergerNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$35.1M disclosed across 5 of 6 rounds · 1900–2023
▶$3MraisedAug 2023 · 1 investors · Other Health CareRule 506(b)
▶$3MraisedAug 2023 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James W. StuckertDirector
- Roszell Mack IIIDirector
- Zachary B. FlemingExecutive Officer
- Ann Beal SalamoneDirector
- Robert A. DeSutterDirector
- Eric D. MajorDirector
- Sara N. OrtweinDirector
- Eric D. TanzbergerDirector
- Ronald T. NixonDirector
- Michael D. McNeilExecutive Officer
- Offering amount
- $3M
- Amount sold
- $3M
- First sale
- Aug 2023
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$16MraisedJul 2022 · 1 investors · Other Health CareRule 506(b)
▶$16MraisedJul 2022 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Ann Beal SalamoneDirector
- Rebecca E. McMahonExecutive Officer
- Christopher A. MorrisonExecutive Officer
- James W. StuckertDirector
- Eric D. TanzbergerDirector
- Shawn M. BowmanExecutive Officer
- Zachary B. FlemingExecutive Officer
- Kenneth E. ThorpeDirector
- Robert A. DeSutterDirector
- Michael D. McNeilExecutive Officer
- Ronald T. NixonDirector
- Sara N. OrtweinDirector
- Roszell Mack IIIDirector
- Offering amount
- $16M
- Amount sold
- $16M
- First sale
- Jul 2022
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$14.5MraisedJun 2022 · 46 investors · Other Health CareRule 506(b)
▶$14.5MraisedJun 2022 · 46 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- James W. StuckertDirector
- Roszell Mack IIIDirector
- Shawn M. BowmanExecutive Officer
- Kenneth E. ThorpeDirector
- Zachary B. FlemingExecutive Officer
- Rebecca E. McMahonExecutive Officer
- Eric D. TanzbergerDirector
- Ann Beal SalamoneDirector
- Michael D. McNeilExecutive Officer
- Robert A. DeSutterDirector
- Sara N. OrtweinDirector
- Christopher A. MorrisonExecutive Officer
- Ronald T. NixonDirector
- Offering amount
- $14.5M
- Amount sold
- $14.5M
- First sale
- Apr 2022
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$500KraisedJul 2021 · 1 investors · Other Health CareRule 506(b)
▶$500KraisedJul 2021 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. McNeilExecutive Officer
- Ronald T. NixonDirector
- Shawn M. BowmanExecutive Officer
- Zachary B. FlemingExecutive Officer
- Ann Beal SalamoneDirector
- Kenneth E. ThorpeDirector
- James W. StuckertDirector
- J. Michael CarmenaDirector, Executive Officer
- Robert A. DeSutterDirector
- Sara OrtweinDirector
- Christopher A. MorrisonExecutive Officer
- Offering amount
- $500K
- Amount sold
- $500K
- First sale
- Jul 2021
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
▶$1.1MraisedJan 2021 · 2 investors · Other Health CareRule 506(b)
▶$1.1MraisedJan 2021 · 2 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- J. Michael CarmenaDirector, Executive Officer
- Robert DeSutterDirector
- Ronald NixonDirector
- Sara OrtweinDirector
- Zachary FlemingExecutive Officer
- James StuckertDirector
- Kenneth ThorpeDirector
- Shawn BowmanExecutive Officer
- Michael McNeilExecutive Officer
- Ann SalamoneDirector
- Offering amount
- $1.1M
- Amount sold
- $1.1M
- First sale
- Jan 2021
- Incorporated
- Corporation, Texas
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 2
Real SelfRealSelf is an online platform where consumers can research cosmetic and aesthetic procedures, read peer reviews with "Worth It" ratings, and view average cost information for treatments such as HydraFacial, PRP injections, and Sculptra. It serves people considering surgical and non-surgical skin rejuvenation and cosmetic treatments.
Net HealthNet Health provides clinical intelligence and specialty software solutions for healthcare organizations delivering wound care, rehabilitation therapy, occupational health, and skilled nursing services.
Companies working in the same space as Sanara MedTech.
In the news
Frequently asked questions
- What does Sanara MedTech do?
- Sanara MedTech is a medical technology company focused on wound care and related healthcare products. The page lists its board of directors and executive leadership.
- How much funding has Sanara MedTech raised?
- Sanara MedTech has disclosed $35.1M raised across 5 of its 6 known rounds.
- Where is Sanara MedTech headquartered?
- Sanara MedTech is headquartered in Fort Worth, US.